Steve Oh | Stem Cell Bioprocessing Director And Institute Professor

Steve Oh, Stem Cell Bioprocessing Director And Institute Professor, A-star

Dr. Steve Oh obtained his PhD from Birmingham University, UK (1990) and is the Director of Stem Cell Bioprocessing and Institute Scientist, Stem Cell Group. He has had several industry leadership roles e.g. Asia-Pacific Vice President of International Society of Cell and Gene Therapy (ISCT); Member of International Society of Stem Cell Research (ISSCR); Member of International Stem Cell Banking Initiative (ISCBI); Vice President of Stem Cell Society Singapore (SCSS). He is also an Adjunct Associate Professor at NTU, PhD Supervisor at A*STAR Graduate Academy and has received research funding grants ranging from SGD 10 to 25 million. He has 42 Patents, granted and pending, 107 scientific publications and created 2 companies: Veristem and Zenzic Labs. His research is on human adult and pluripotent stem cell bioprocessing. Our team has developed a range of patent families for the manufacture of mesenchymal stem cells, reprogrammed human induced pluripotent stem cells and created neural cells, cardiomyocytes, blood cells, cartilage, bone and retinal pigment epithelial cells at bioreactor scale using a range of microcarrier technologies including biodegradable ones. Most recently, we have achieved a novel method of directed differentiation using CRISPR technology that will accelerate therapeutic applications of stem cells.


Day 1: Wednesday 19th May 2021 - Cell Therapy @ 17:00

Roundtable: Suspension, perfusion and continuous processing

last published: 10/May/21 08:45 GMT

back to speakers